CPHI
Price
$1.39
Change
-$0.03 (-2.11%)
Updated
Aug 29, 04:53 PM (EDT)
Capitalization
4.63M
PAHC
Price
$36.69
Change
-$1.77 (-4.60%)
Updated
Aug 29, 04:13 PM (EDT)
Capitalization
1.56B
68 days until earnings call
Interact to see
Advertisement

CPHI vs PAHC

Header iconCPHI vs PAHC Comparison
Open Charts CPHI vs PAHCBanner chart's image
China Pharma Holdings
Price$1.39
Change-$0.03 (-2.11%)
Volume$230
Capitalization4.63M
Phibro Animal Health
Price$36.69
Change-$1.77 (-4.60%)
Volume$7.1K
Capitalization1.56B
CPHI vs PAHC Comparison Chart in %
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. PAHC commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a Hold and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CPHI: $1.42 vs. PAHC: $38.46)
Brand notoriety: CPHI and PAHC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPHI: 65% vs. PAHC: 341%
Market capitalization -- CPHI: $4.63M vs. PAHC: $1.56B
CPHI [@Pharmaceuticals: Generic] is valued at $4.63M. PAHC’s [@Pharmaceuticals: Generic] market capitalization is $1.56B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than CPHI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 5 TA indicator(s) are bullish while PAHC’s TA Score has 4 bullish TA indicator(s).

  • CPHI’s TA Score: 5 bullish, 4 bearish.
  • PAHC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than PAHC.

Price Growth

CPHI (@Pharmaceuticals: Generic) experienced а -4.05% price change this week, while PAHC (@Pharmaceuticals: Generic) price change was +21.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

PAHC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAHC($1.56B) has a higher market cap than CPHI($4.63M). PAHC YTD gains are higher at: 84.973 vs. CPHI (-38.925). PAHC has higher annual earnings (EBITDA): 123M vs. CPHI (-1.74M). PAHC has more cash in the bank: 70.4M vs. CPHI (625K). CPHI has less debt than PAHC: CPHI (3.43M) vs PAHC (770M). PAHC has higher revenues than CPHI: PAHC (1.19B) vs CPHI (4.4M).
CPHIPAHCCPHI / PAHC
Capitalization4.63M1.56B0%
EBITDA-1.74M123M-1%
Gain YTD-38.92584.973-46%
P/E RatioN/A32.32-
Revenue4.4M1.19B0%
Total Cash625K70.4M1%
Total Debt3.43M770M0%
FUNDAMENTALS RATINGS
CPHI vs PAHC: Fundamental Ratings
CPHI
PAHC
OUTLOOK RATING
1..100
5024
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
10044
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9139
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (29) in the Pharmaceuticals Major industry is in the same range as CPHI (46) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to CPHI’s over the last 12 months.

PAHC's Profit vs Risk Rating (44) in the Pharmaceuticals Major industry is somewhat better than the same rating for CPHI (100) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew somewhat faster than CPHI’s over the last 12 months.

PAHC's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to CPHI’s over the last 12 months.

PAHC's Price Growth Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for CPHI (91) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew somewhat faster than CPHI’s over the last 12 months.

PAHC's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHIPAHC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 24 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FASMX22.20N/A
N/A
Fidelity Asset Manager 50%
EIVDX16.19N/A
N/A
Allspring Special Large Cap Value Admin
THGIX26.76N/A
N/A
Thornburg International Growth R6
BRIIX17.08N/A
N/A
Baron Real Estate Income Institutional
BAILX11.82N/A
N/A
Brown Advisory Sustainable Intl Ldrs Ins

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with AMRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+19.44%
AMRX - PAHC
48%
Loosely correlated
+2.03%
PBH - PAHC
44%
Loosely correlated
+0.45%
ZTS - PAHC
43%
Loosely correlated
-0.37%
ELAN - PAHC
39%
Loosely correlated
-0.22%
VTRS - PAHC
38%
Loosely correlated
-0.10%
More